Find what you are looking for

Need help?
Questions?
We will be glad to help you

Contact us

Neuroalivio

Description
  • Behavioral disorder modifier.
  • For dogs.
  • Palatable tablets.
Formula

Each tablet contains:

Buspirone ……………………………………….40  mg
Excipients q.s. …………………………….. 2000 mg

Indications

Neuroalivio is a behavior modifier for animals’ abnormal conduct caused by mild or severe anxiety such as:

  • Separation anxiety disorder evidenced by damages such as: damages caused during the owners’ absence, excessive barking and wailing, bowel movement and urine incontinence in inappropriate places, except for the normal marking of males.
  • Compulsive behavior evidenced by: tail chasing, acral lick granuloma, flank licking.
  • Dominance aggression or fearful aggression evidenced by: threatening growling when receiving orders, lack of obedience.
  • Adaptation issues towards new situations such as: the presence of a new member in the house (baby, new animals); temporary or definitive absence of a family member; adjustment to changes of environment.
  • Slightly fearful behavior evidenced by: refusal to leave the house; difficulties in walking during strolls.
  • Neuroalivio also eases the correctional learning of behavioral disorders.

Important notice: In order to achieve maximum therapeutic effect of Neuroalivio, the treatment should be given with the corrective therapy for the underlying pathology.

Package

Container with 30 palatable tablets.

Prospect Share Registered in
  • Argentina
  • Brazil
  • Ecuador
  • Paraguay
  • Peru
  • Uruguay